Eisai To Distribute Ajinomoto Drugs In 11 Asian Nations Outside Japan
This article was originally published in PharmAsia News
Executive Summary
Japan's Ajinomoto has arranged for Esai to distribute its Livact Granules (amino acid) hepatic liver cirrhosis drug in Asian countries outside Japan. The two companies also are discussing having Esai get approval for and distribute other Ajinomoto digestive system drugs abroad as part of the company's goal of a 20 percent sales increase. The Livact agreement calls for Esai to target nine countries: Cambodia, China, India, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Sri Lanka, Thailand and Vietnam. (Click here for more - a subscription may be required